NCT00787995
MPS IVA, Morquio A Syndrome, Mucopolysaccharidosis IVA, MPS IV A
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
This multicenter, multinational, longitudinal study will quantify endurance and respiratory function in subjects diagnosed with MPS IVA and will better characterize the spectrum of symptoms and biochemical abnormalities in MPS IVA disease over time.
All
Any
No
Observational
353
2008-10
2014-12-08
Oakland, California, United States
Chicago, Illinois, United States
Cordoba, , Argentina
Porto Alegre, , Brazil
Sao Paulo, , Brazil
Montreal, Quebec, Canada
Lyon, , France
Paris, , France
Mainz, , Germany
Monza, , Italy
Amsterdam, , Netherlands
Taipei, , Taiwan
Birmingham, , United Kingdom
London, , United Kingdom
Manchester, , United Kingdom
By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.
*required fields
"*" indicates required fields